| Literature DB >> 29103078 |
Sheylla Foligno de Carvalho Menezes de Almeida1, Joanna Maria Gonçalves Souza-Fabjan2, Mario Felipe Alvarez Balaro1, Gláucia Mota Bragança1, Pedro Henrique Nicolau Pinto1, José Gabriel de Almeida1, Ana Beatriz Bossois Moura1, Jeferson Ferreira da Fonseca3, Felipe Zandonadi Brandão1.
Abstract
This study evaluated the effect of two doses of prostaglandin at different intervals on reproductive parameters of crossbred ewes. In Experiment 1, 30 ewes received two doses of 120 μg cloprostenol at 7 (G 7 days), 9 (G 9 days), or 11.5 (G 11.5 days) days apart. Ultrasound assessments were performed from the first and second cloprostenol administration for 5 days or ovulation detection. Estrus signs were checked by a teaser male. Plasma progesterone concentration was measured before each cloprostenol dose. In Experiment 2, 95 ewes were allocated into the same treatments and after the second dose, ewes in estrus were mated. At 30 days after breeding, pregnancy diagnosis was conducted and prolificacy was evaluated at lambing. In Experiment 1, at the first cloprostenol administration, 50% of ewes had an active CL and all showed estrus. At the second administration, 66.7% of ewes had an active CL and one did not present estrus. There was no difference (P > 0.05) after the second dose for as follows: overall estrous response (90%), interval from cloprostenol administration to estrous onset (42.0 ± 4.9 h), estrus duration (31.5 ± 2.1 h), ovulation rate (100.0%), and number of ovulations (1.5 ± 0.3). In Experiment 2, both pregnancy and prolificacy rates were similar (P > 0.05) for G 7 days (73.3; 145%), G 9 days (75.9; 125%), or G 11.5 days (75.9; 145%), leading to an overall pregnancy rate of 75.0% (66/88) and prolificacy rate of 137%. Therefore, the three treatments proposed were able to promote high pregnancy and prolificacy rates in crossbred ewes.Entities:
Keywords: Cyclicity; Native breed; Ovine; Progesterone; Prostaglandin
Mesh:
Substances:
Year: 2017 PMID: 29103078 DOI: 10.1007/s11250-017-1454-x
Source DB: PubMed Journal: Trop Anim Health Prod ISSN: 0049-4747 Impact factor: 1.559